Article

Aspheric monofocal lens tops spheric lens for contrast sensitivity, study finds

Author(s):

London-In an intra-individual comparison of spheric and aspheric monofocal IOLs, significantly better contrast sensitivity was observed in eyes in which the aspheric lens had been implanted, but there was no difference in best-corrected visual acuity (BCVA), said Katrin Petermeier, MD, University Eye Hospital, Eberhard-Karls University, Tuebingen, Germany.

Dr. Petermeier, who conducted the study with colleagues Elke Altpeter, MD, and Peter Szurman, MD, presented the postoperative results here at the annual congress of the European Society of Cataract and Refractive Surgeons.

BCVA was analyzed using the ETDRS charts. Low-contrast visual acuity was assessed with Pelli-Robson charts. Photopic and mesopic contrast sensitivity were measured by functional acuity contrast tests using the Ginsburg Box. Spatial frequencies tested were 1.5, 3, 6, 12, and 18 cycles per degree at photopic (85 cd/m2 ) and mesopic (6 cd/m2 ) luminance levels; mesopic contrast sensitivity also was measured with glare (35 lux).

Follow-up results

At the 12-week follow-up, 44 patients were available; only 32 patients were necessary to give the study statistical significance, so the results were statistically valid.

Significantly better contrast sensitivity was observed with the aspheric lens, Dr. Petermeier said.

"Intra-individual comparison showed 20% higher contrast sensitivity for the [aspheric lens] at all spatial frequencies tested and under all three illumination states," she explained.

The difference in BCVA, low-contrast visual acuity, and residual refractive error between lenses was not statistically significant.

According to Dr. Petermeier, the most important outcome from this study is the superior performance of an aspheric lens compared with a spheric lens.

"It's the aspheric lens design that provides better contrast sensitivity," she said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.